Are plasma leptin levels associated with baseline and longitudinal changes of the 2 key protein pathologies of Alzheimer disease (AD), amyloid-beta (Aβ) and tau deposition, as measured by positron emission tomography among cognitively normal older adults? This evidence concerns the gene MAPT and Alzheimer disease.